Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

Abstract

The management of patients with brain metastases has become a major issue due to the increasing frequency and complexity of the diagnostic and therapeutic approaches. In 2014, the European Association of NeuroOncology (EANO) created a multidisciplinary Task Force to draw evidence-based guidelines for patients with brain metastases from solid tumors. Here, we present these guidelines, which provide a consensus review of evidence and recommendations for diagnosis by neuroimaging and neuropathology, staging, prognostic factors, and different treatment options. Specifically, we addressed options such as surgery, stereotactic radiosurgery/stereotactic fractionated radiotherapy, whole-brain radiotherapy, chemotherapy and targeted therapy (with particular attention to brain metastases from non-small cell lung cancer, melanoma and breast and renal cancer), and supportive care. Key wordsbrain metastases | chemotherapy | neuroimaging | neuropathology | stereotactic radiosurgery/stereotactic fractionated radiotherapy | supportive care | surgery | targeted therapy | whole-brain radiation therapy

Combination of apatinib and continuous nutritional support for a gastric cancer patient with brain metastasis prolongs survival

“…Brain metastasis from gastric cancer significantly increases the risk of death. The main therapeutic methods in the therapy of brain metastasis from gastric cancer include surgery, whole‐brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) . In this study, we report the first case of brain metastasis from gastric cancer, treated by apatinib and continual nutritional support.…”

Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSG

“…Although some patients undoubtedly benefit from these targeted therapies, the overall prognosis for brain metastases is generally poor, and there are few effective treatments that can achieve long-term control 11,12 .…”

Detection of circulating tumor DNA from non‐small cell lung cancer brain metastasis in cerebrospinal fluid samples

“…The reported annual incidence of brain metastases is 8.3–14.3 per 100 000 people . Brain metastases are found in 8%–20% of patients with cancer, but the frequency is even higher on autopsy . In addition, brain metastasis is 10 times more common than primary brain tumor .…”